Incannex Healthcare Limited (ASX:IHL) Amended Loyalty Options Timetable

Melbourne, Australia, March 21, 2022 – Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs.
A revised timetable for the issue of Loyalty Options can be accessed through the button below.